Literature DB >> 20375216

Approach to the patient with Turner syndrome.

Marsha L Davenport1.   

Abstract

Turner syndrome (TS) occurs in about 1:4000 live births and describes females with a broad constellation of problems associated with loss of an entire sex chromosome or a portion of the X chromosome containing the tip of its short arm. TS is associated with an astounding array of potential abnormalities, most of them thought to be caused by haploinsufficiency of genes that are normally expressed by both X chromosomes. A health care checklist is provided that suggests screening tests at specific ages and intervals for problems such as strabismus, hearing loss, and autoimmune thyroid disease. Four areas of major concern in TS are discussed: growth failure, cardiovascular disease, gonadal failure, and learning disabilities. GH therapy should generally begin as soon as growth failure occurs, allowing for rapid normalization of height. Cardiac imaging, preferably magnetic resonance imaging, should be performed at diagnosis and repeated at 5- to 10-yr intervals to assess for congenital heart abnormalities and the emergence of aortic dilatation, a precursor to aortic dissection. Hypertension should be aggressively treated. For those with gonadal dysgenesis, hormonal replacement therapy should begin at a normal pubertal age and be continued until the age of 50 yr. Transdermal estradiol provides the most physiological replacement. Finally, nonverbal learning disabilities marked by deficits in visual-spatial-organizational skills, complex psychomotor skills, and social skills are common in TS. Neuropsychological testing should be routine and families given support in obtaining appropriate therapy, including special accommodations at school.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20375216     DOI: 10.1210/jc.2009-0926

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  46 in total

1.  Medically underserved girls receive less evaluation for short stature.

Authors:  Adda Grimberg; Kristen A Feemster; Susmita Pati; Mark Ramos; Robert Grundmeier; Andrew J Cucchiara; Virginia A Stallings
Journal:  Pediatrics       Date:  2011-03-21       Impact factor: 7.124

2.  Altered lymphatics in an ovine model of congenital heart disease with increased pulmonary blood flow.

Authors:  Sanjeev A Datar; Eric G Johnson; Peter E Oishi; Michael Johengen; Eric Tang; Angela Aramburo; Jubilee Barton; Hsuan-Chang Kuo; Stephen Bennett; Konstantine Xoinis; Bhupinder Reel; Gokhan Kalkan; Eniko Sajti; Oscar Osorio; Gary W Raff; Michael A Matthay; Jeffrey R Fineman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-12-29       Impact factor: 5.464

3.  Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Charmian A Quigley; Xiaohai Wan; Sipi Garg; Karen Kowal; Gordon B Cutler; Judith L Ross
Journal:  J Clin Endocrinol Metab       Date:  2014-04-24       Impact factor: 5.958

4.  Commentary: Launch of a quality improvement network for evidence-based management of uncommon pediatric endocrine disorders: Turner syndrome as a prototype.

Authors:  Robert L Rosenfield; Linda A DiMeglio; Nelly Mauras; Judith Ross; Natalie D Shaw; Siri A W Greeley; Morey Haymond; Karen Rubin; Erinn T Rhodes
Journal:  J Clin Endocrinol Metab       Date:  2015-04       Impact factor: 5.958

5.  Response to three years of growth hormone therapy in girls with Turner syndrome.

Authors:  Hong Kyu Park; Hae Sang Lee; Jung Hee Ko; Il Tae Hwang; Jin Soon Hwang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2013-03-31

Review 6.  Growth hormone treatment in non-growth hormone-deficient children.

Authors:  Sandro Loche; Luisanna Carta; Anastasia Ibba; Chiara Guzzetti
Journal:  Ann Pediatr Endocrinol Metab       Date:  2014-03-31

7.  Medical treatment in gender dysphoric adolescents endorsed by SIAMS-SIE-SIEDP-ONIG.

Authors:  A D Fisher; J Ristori; E Bandini; S Giordano; M Mosconi; E A Jannini; N A Greggio; A Godano; C Manieri; C Meriggiola; V Ricca; D Dettore; M Maggi
Journal:  J Endocrinol Invest       Date:  2014-05-27       Impact factor: 4.256

8.  Psychosocial functioning and social cognitive processing in girls with Turner syndrome.

Authors:  David S Hong; Bria Dunkin; Allan L Reiss
Journal:  J Dev Behav Pediatr       Date:  2011-09       Impact factor: 2.225

9.  Dual diagnoses in 152 patients with Turner syndrome: Knowledge of the second condition may lead to modification of treatment and/or surveillance.

Authors:  Kelly L Jones; Erin A McNamara; Mauro Longoni; Danny E Miller; Mersedeh Rohanizadegan; Laura A Newman; Frances Hayes; Lynne L Levitsky; Betty L Herrington; Angela E Lin
Journal:  Am J Med Genet A       Date:  2018-08-06       Impact factor: 2.802

Review 10.  The patient with Turner syndrome: puberty and medical management concerns.

Authors:  Luisa Gonzalez; Selma Feldman Witchel
Journal:  Fertil Steril       Date:  2012-08-09       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.